These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20541966)

  • 1. Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection.
    Halfon P; Benmoura D; Agostini A; Khiri H; Penaranda G; Martineau A; Blanc B
    J Clin Virol; 2010 Aug; 48(4):246-50. PubMed ID: 20541966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
    Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B
    J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections.
    Baleriola C; Millar D; Melki J; Coulston N; Altman P; Rismanto N; Rawlinson W
    J Clin Virol; 2008 May; 42(1):22-6. PubMed ID: 18262463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
    Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.
    Prétet JL; Dalstein V; Monnier-Benoit S; Delpeut S; Mougin C
    J Clin Virol; 2004 Oct; 31(2):140-7. PubMed ID: 15364271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups.
    Leo E; Venturoli S; Cricca M; Musiani M; Zerbini M
    J Clin Virol; 2009 Aug; 45(4):304-10. PubMed ID: 19473874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
    Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
    Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
    Eder PS; Lou J; Huff J; Macioszek J
    J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears referred to colposcopy.
    Halfon P; Benmoura D; Agostini A; Khiri H; Pénaranda G; Martineau A; Blanc B
    Cancer Biomark; 2010; 7(3):133-9. PubMed ID: 21263189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.
    Poljak M; Oštrbenk A
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
    Barzon L; Militello V; Pagni S; Palù G
    J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal ProbeLibrary based real-time PCR assay for detection and confirmation of human papillomavirus genotype 52 infections.
    Kocjan BJ; Poljak M; Seme K
    J Virol Methods; 2010 Feb; 163(2):492-4. PubMed ID: 19883693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.
    Harvey M; Stout S; Starkey CR; Hendren R; Holt S; Miller GC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S79-83. PubMed ID: 19651373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles and analytical performance of Abbott RealTime High Risk HPV test.
    Huang S; Tang N; Mak WB; Erickson B; Salituro J; Li Y; Krumpe E; Schneider G; Yu H; Robinson J; Abravaya K
    J Clin Virol; 2009 Jul; 45 Suppl 1():S13-7. PubMed ID: 19651363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
    Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
    J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.